NIFTY MIDCAP 150: Coromandel Int Up 2.71%, Global Health 2.69% Among Top Gainers

Persistent Systems closed at ₹5724.00 on July 9, 2025, marking a 1.04% decline from its previous close of ₹5784.00. The stock closed below its 50-Day Simple Moving Average (SMA) of ₹5767.75.

Metric	Value
Closing Price	₹5724.00
Previous Close	₹5784.00
Daily Change	-1.04%
50-Day SMA	₹5767.75
Trading Volume	276308

The close below the 50-Day SMA signals a bearish sentiment for the stock in the short term. Technical indicators like RSI (40.22) and CCI (-180.98) also suggest bearish momentum. Recent investor sessions by Persistent Systems have consistently reiterated previously disclosed information, with no new price-sensitive details shared. The company has recommended a final dividend of ₹15 per share for FY25, and leadership continuity is expected with the proposed re-appointment of Dr. Anand Deshpande and Mr. Sandeep Kalra, pending shareholder approval at the upcoming AGM on July 21, 2025.

Deepak Nitrite's shares closed at ₹1980.70 today, marking a marginal gain of 0.09% from its previous close. This close is notably above its 50-Day Moving Average (DMA) of ₹1980.55, a key technical indicator often watched by traders. The stock opened at ₹1985, touched a high of ₹1990.1, and a low of ₹1976 during the trading session. This move above the 50-DMA is generally considered a bullish signal, suggesting potential positive momentum for the stock in the short to medium term.

Oberoi Realty closed at ₹1831.10 today, marking a 1.42% decline and falling below its 200-Day Moving Average (DMA) of ₹1844.99. This technical breach signals a bearish sentiment for the stock, as the 200-DMA is a key long-term trend indicator. The stock's closing price was ₹1831.10, with the 200-DMA at ₹1844.99. Technical indicators for the stock, including the 5-day, 10-day, and 20-day Simple Moving Averages, also show a bearish indication.

Closing below the 200-DMA is often interpreted as a significant bearish signal, suggesting potential downward pressure and a shift in the long-term trend. This development may influence investor sentiment, particularly for those monitoring long-term technical patterns. The company's trading window is currently closed in anticipation of its Q1 FY26 financial results, which are expected to be released soon and will be a key event for investors to monitor for future direction.

Premier Energie Ltd. closed at ₹1074.10 today, marking a 1.66% gain and successfully trading above its 200-Day Moving Average of ₹1057.12. This technical breakout is supported by recent positive fundamental developments, including a credit rating upgrade by CRISIL to 'A/Positive' for long-term facilities and 'A1' for short-term, reflecting improved operational scale and financial health. The company also recently commissioned a new 1.2 GW TOPCon solar cell manufacturing line, increasing its total capacity to 3.2 GW, and incorporated a new subsidiary for energy storage solutions.

The stock, part of the NIFTY MIDCAP 150 index, saw a trading volume of 2,440,011 shares. The positive momentum follows strong FY25 financials, with consolidated operating income more than doubling to ₹6,518 crore and EBITDA margin expanding significantly to 27.3%. Investors will now look towards the upcoming Q1 FY26 results, for which the trading window has been closed since July 1, 2025.

Container Corporation of India (CCI) closed at ₹615.35 today, marking a 2.84% gain and successfully closing above its 30-Day and 200-Day Moving Averages. This technical breakout signals bullish momentum, likely supported by recent positive corporate actions. The company's 200-Day Simple Moving Average stands at ₹609.66, indicating a strong upward trend as the stock trades above this key long-term indicator.

The positive sentiment follows the recent approval by shareholders for a 1:4 bonus issue, with the record date set for July 4, 2025, and bonus shares expected to commence trading from July 8, 2025. Additionally, CONCOR recently launched a new, innovative service for bulk cement transportation using specialized tank containers, a first in India, which is expected to enhance operational efficiency and diversify revenue streams. The trading window for CCI's equity shares is currently closed from July 1, 2025, until 48 hours after the declaration of its Q1 FY26 financial results, signaling upcoming earnings that will provide further insights into the company's performance.

Max Financial Services closed at ₹1563.70 today, marking a 0.53% decline and falling below its 30-Day Moving Average of ₹1569.00. This technical breach often signals a bearish sentiment in the short term.

Metric	Value
Closing Price	₹1563.70
Daily Change	-0.53%
30-Day Moving Average	₹1569.00

The stock's performance today comes ahead of its Board meeting scheduled for August 7, 2025, where the company will consider and approve its un-audited Q1 FY26 financial results. The trading window for designated persons is currently closed until August 9, 2025, in compliance with SEBI regulations. Recently, Mr. Sumit Madan was appointed as the MD & CEO of Axis Max Life Insurance Limited, effective October 1, 2025. The company also conducted analyst/institutional investor meetings in the US on June 25, 2025, with no unpublished price-sensitive information discussed.

Jubilant Foodworks (JUBLFOOD) closed at ₹682.95 today, marking a 0.76% decline and falling below its crucial 50-Day and 150-Day Moving Averages. This technical breach typically signals a bearish sentiment for the stock. Recent developments, including the promoter Jubilant Consumer Private Limited's sale of 1.66% stake (1,09,80,000 equity shares) via a block deal on June 13, 2025, and the extended timeline for the divestment of its Russian operations to May 30, 2026, due to regulatory requirements, may be contributing to investor caution. The company also recently closed its trading window from July 1, 2025, in compliance with SEBI regulations ahead of its Q1 FY26 financial results, which are yet to be announced.

NMDC closed at ₹67.90 today, marking a 0.57% decline and falling below its 150-Day Moving Average of ₹68.07. This technical breach comes amidst a "Very Bearish" sentiment indicated by various technical metrics, including an RSI of 43.20 and MACD at -0.48. The stock's performance is also influenced by recent Q4 FY25 results, which, despite a significant 53.77% YoY revenue increase to ₹2,838.25 crore and a narrowed quarterly net loss to ₹473.39 crore, revealed a widened full-year net loss of ₹2,373.78 crore for FY25. Furthermore, the company faces persistent corporate governance issues, having incurred fines of ₹56,85,240 each from BSE and NSE for non-compliance with SEBI regulations regarding board composition and committee formation. Investors will be closely watching the upcoming Q1 FY26 results, for which the trading window has already closed, to gauge future operational improvements and address governance concerns.

Mankind Pharma closed at ₹2526.60 today, marking a significant 3.90% gain and successfully trading above its 150-Day and 200-Day Moving Averages. This technical breakout suggests a potential shift in momentum for the stock, often interpreted as a bullish signal by market participants.

The stock's closing price of ₹2526.60 surpassed its 200-Day Simple Moving Average (SMA) of ₹2520.26 and its 200-Day Exponential Moving Average (EMA) of ₹2419.58. This breach above long-term moving averages indicates strengthening investor confidence and a potential for continued upward movement. The company has also announced the closure of its trading window for designated persons, signaling that its Q1 FY26 financial results are expected to be released in the coming weeks, which will be a key event for investors.

AWL Agri Business closed at ₹262.75 today, marking a 0.19% decline from its previous close of ₹263.25, and falling below its 30-Day Moving Average of ₹263.23. The stock traded with a volume of 1,849,784 shares. This technical breach suggests a potential shift in short-term momentum, aligning with bearish signals from multiple moving average crossovers (5 & 20 DMA, 20 & 50 DMA, 50 & 200 DMA). The company recently provided a preliminary Q1 FY26 update, reporting a 4% YoY volume decline but a 21% YoY revenue growth, primarily driven by higher edible oil realizations and strategic portfolio adjustments, including the discontinuation of low-margin G2G rice business. The trading window for AWL Agri Business has been closed since July 1, 2025, in anticipation of its Q1 FY26 financial results, which investors will closely monitor for detailed performance insights.

Emami closed at ₹609.15 today, registering a significant gain of 6.20%. This strong performance pushed the stock above its 30-Day, 50-Day, and 150-Day Moving Averages, a technical indicator often signaling positive momentum and a potential shift in trend for the stock.

The stock's movement above these key technical levels suggests a strengthening trend, which could attract further investor interest. This technical breakout indicates a bullish sentiment among traders, potentially setting the stage for continued upward movement in the short to medium term.

The NIFTY MIDCAP 150 index saw strong gains today, with Emami leading the pack, surging 6.07% to ₹608.40. FSN E-Co Nykaa followed with a 5.06% increase, closing at ₹212.85. Other significant gainers included Global Health, Coromandel International, and MRF.

Company	Price (₹)	% Change
Emami	608.40	6.07%
FSN E-Co Nykaa	212.85	5.06%
Global Health	1,272.80	4.49%
Coromandel Int	2,292.30	3.84%
MRF	150,500.00	3.83%

Global Health's 4.49% rise comes amidst recent corporate actions, including the allotment of 110,000 new equity shares generating ₹10.30 crore and ongoing analyst/institutional investor meetings. Coromandel International's 3.84% gain follows its announcement of a proposed final and special dividend for FY24-25, with the record date set for July 17, 2025, and its upcoming 63rd AGM on July 24, 2025. MRF's 3.83% increase is noted ahead of its 64th AGM on August 7, 2025, and the final dividend record date of July 18, 2025. No specific recent news was found in the provided context for Emami or FSN E-Co Nykaa to explain their significant movements.

Global Health and MRF have closed their trading windows from July 1, 2025, in anticipation of their Q1 FY26 unaudited financial results, signaling upcoming earnings announcements. Coromandel International's proposed dividend is subject to shareholder approval at its AGM.

GMR Airports shares advanced by 1.71% to ₹92.80, with a price change of ₹1.56, driven by significant trading volume of 23,759,962 shares. The stock's movement comes as the company continues to report robust operational performance and execute strategic initiatives. Its 52-week high stands at ₹103.75, while the 52-week low is ₹67.75.

The positive sentiment is supported by recent traffic data for May 2025, which saw overall passenger traffic (excluding Cebu) increase by 0.8% year-on-year to 10.02 million, with year-to-date FY26 traffic reaching a record high of 20.36 million, up 4.5% year-on-year. Hyderabad Airport was a key growth driver, experiencing a 15.3% year-on-year surge in passenger traffic. Additionally, GMR Airports recently completed the acquisition of a 70% equity stake in ESR GMR Logistics Park Private Limited, consolidating its airport-based industrial and warehousing portfolio. The company has also initiated a postal ballot for the internal transfer of assets from Delhi Duty Free Services Private Limited to the parent company for approximately ₹350 crore, ensuring business continuity for duty-free operations at Delhi Airport.

The NIFTY MIDCAP 150 index witnessed notable declines on Wednesday, July 9, 2025, with several key stocks registering significant losses. Max Healthcare led the fall, dropping 3.84% to ₹1,246.00, followed by Union Bank, which declined 3.65% to ₹144.76. Phoenix Mills also saw a substantial dip of 3.47% to ₹1,520.00.

Other prominent losers included Sundaram Fin, down 3.07% to ₹5,016.50, and Hind Zinc, which fell 2.52% to ₹425.20. These movements indicate selling pressure across diverse sectors within the midcap segment, including healthcare, banking, real estate, finance, and metals, contributing to the overall sentiment in the NIFTY MIDCAP 150.

The NIFTY MIDCAP 150 index saw several stocks emerge as top gainers today. Emami led the pack, closing at ₹608.40 with a significant gain of 6.07%. Following closely was FSN E-Commerce Ventures (Nykaa), which rose by 5.06% to ₹212.85. Global Health (Medanta) also posted strong gains, increasing by 4.49% to ₹1,272.80, while Coromandel International climbed 3.84% to ₹2,292.30. MRF rounded out the top performers, advancing 3.83% to ₹150,500.00.

Global Health's rise comes amidst recent equity share allotments, including 90,000 shares under the GHL LTIP 2024 Plan at ₹1,144 per share, generating approximately ₹10.30 crore in cash inflow and signaling strong employee confidence. Coromandel International and MRF's positive movements follow their respective announcements of proposed final and special dividends for FY2024-25, subject to shareholder approval at their upcoming AGMs. Coromandel's AGM is scheduled for July 24, 2025, with a record date of July 17, 2025, while MRF's AGM is on August 7, 2025, with a record date of July 18, 2025. These dividend proposals likely contributed to the positive sentiment surrounding these stocks.

GMR Airports stock surged by 1.71%, closing at ₹92.80, marking a gain of ₹1.56. This positive movement was accompanied by high trading volume, with 23,759,962 shares traded today. The stock is currently trading closer to its 52-week high of ₹103.75, significantly above its 52-week low of ₹67.75.

The upward trend is likely influenced by recent positive developments, including the company's May 2025 traffic data, which showed overall passenger traffic (excluding Cebu) increasing by 0.8% year-on-year to 10.02 million, and a record YTD FY26 traffic of 20.36 million, up 4.5% YoY. Hyderabad Airport was a notable performer, with passenger traffic up 15.3% YoY. Additionally, the completion of the acquisition of a 70% equity stake in ESR GMR Logistics Park Private Limited and the strategic internal asset transfer of Delhi Duty Free Services Private Limited's assets for approximately ₹350 crore, ensuring business continuity, have contributed to investor confidence. The company has also initiated a trading window closure ahead of its Q1 FY26 unaudited financial results, with a postal ballot regarding the DDFS asset sale results expected by July 25, 2025.

The NIFTY MIDCAP 150 index saw significant declines in several key constituents today, July 9, 2025. Max Healthcare led the losses, dropping 3.84% to close at ₹1,246.00. Union Bank followed, shedding 3.65% to ₹144.76, while Phoenix Mills declined by 3.47% to ₹1,520.00. Sundaram Finance also experienced a notable fall of 3.07% to ₹5,016.50, and Hind Zinc was down 2.52% at ₹425.20.

These movements indicate a broad-based selling pressure across various sectors within the midcap space, including healthcare, banking, real estate, financial services, and metals. Investors holding these specific midcap stocks are directly impacted by these declines.

Company	Closing Price	% Change
Max Healthcare	₹1,246.00	-3.84%
Union Bank	₹144.76	-3.65%
Phoenix Mills	₹1,520.00	-3.47%
Sundaram Fin	₹5,016.50	-3.07%
Hind Zinc	₹425.20	-2.52%

IRCTC - Indian Railway Catering is currently trading at ₹785.15, experiencing a marginal dip of -0.01% today, accompanied by a market alert indicating high and surging trading volume. Today's volume stands at 1.6 million shares (1,595,848), notably higher than its 1-week average of 893,360 shares and 1-month average of 1,006,356 shares. While the stock has gained 1.35% over the past week and 0.81% in the last month, it has seen a 0.11% decline year-to-date and a 24.83% drop over the last year. The marginal price movement despite high volume suggests a balanced market sentiment, influenced by recent retail investor interest in railway stocks due to India's infrastructure push and consistent order flows. Technical analysis from early July indicated IRCTC was nearing a potential breakout zone around ₹790. Looking ahead, Prabhudas Lilladher maintained a "BUY" rating with a target of ₹864 (May 30, 2025), anticipating a 13% top-line CAGR for the catering division. Additionally, Indian Railways' digital overhaul, implemented through IRCTC, has led to a 19.53% increase in average daily user logins and an 11.85% growth in daily ticket bookings, which could further support its future performance.

IRCTC - Indian Railway Catering & Tourism Corp Ltd. experienced a market alert for high volume today. While a momentary dip of -0.01% was noted, the stock ultimately closed marginally higher by 0.05% at ₹785.60. The shares are part of the NIFTY MIDCAP 150 index.

The stock's current price stands at ₹785.60, reflecting a gain of ₹0.40 (+0.05%) for the day. Today's trading volume reached 1,428,886 shares. IRCTC's 52-week high is ₹1,059.45 and its 52-week low is ₹656.00. Prabhudas Lilladher has a target price of ₹864 (May 30, 2025), while a recent Trade Spotlight recommended a target of ₹825 (July 3, 2025).

The high volume and marginal gain come amid several positive developments for the railway sector. Indian Railways is reportedly considering fare hikes for AC and non-AC trains, which could potentially boost IRCTC's revenue. Furthermore, the recent revamp of the tatkal booking system has led to a 19.53% increase in average daily user logins and an 11.85% rise in daily ticket bookings for IRCTC. The company also reported robust Q4 FY25 results, with Net Sales up 9.85% and Net Profit up 25.88% year-on-year.

Analysts continue to show confidence in IRCTC, with 'Buy' ratings and target prices ranging from ₹825 to ₹864. The stock is currently approaching a potential breakout zone near ₹790, suggesting continued investor interest driven by the sector's growth prospects and ongoing infrastructure push.

MRF shares touched an all-time high of Rs 151,450.00 on the National Stock Exchange (NSE), marking a significant milestone for the tyre major. The stock surged by 4.48% during the trading session.

This surge reflects strong investor confidence in MRF, potentially driven by positive market sentiment towards the company. The stock's robust performance could positively influence sentiment for other players in the tyre sector.

Ola Electric Mobility shares plummeted to an all-time low of ₹40.26 on the NSE, currently trading at ₹40.34, down 1.03%. This decline follows the company's recent financial results, which revealed a significant widening of losses and a sharp drop in Q4 FY25 revenue and deliveries. The stock is part of the NIFTY MIDCAP 150 index.

For FY25, Ola Electric's consolidated net loss widened to ₹2,276 crore from ₹1,584 crore in FY24. Q4 FY25 saw consolidated revenue drop by 39.3% QoQ to ₹649 crore, with consolidated EBITDA loss widening to ₹658 crore, reflecting a margin of -101.4%. Operating cash flow remained negative at ₹2,391 crore for FY25. Despite these challenges, the company maintains a strong cash position of approximately ₹4,000 crore and targets Auto segment EBITDA profitability in FY26, with Q1 FY26 guidance projecting 65,000 deliveries and an improved Auto Gross Margin of 28-30%.

MRF shares surged to a new 52-week high of Rs 151,450.00 on the National Stock Exchange (NSE), marking a significant gain of 4.48%. This strong performance positions MRF within the NIFTY MIDCAP 150 index, reflecting robust investor confidence in the tyre major.

The stock's ascent to this new peak highlights strong buying interest and positive sentiment surrounding the company. This movement indicates a significant upward momentum for MRF, pushing its valuation to a new high.

MRF Limited has achieved an all-time high of ₹151,450.00 on the National Stock Exchange (NSE), marking a significant gain of 4.48% during today's trading session. This surge follows a period of strong performance and positive corporate announcements for the tyre manufacturer, which is a constituent of the NIFTY MIDCAP 150 index.

The stock's current price stands at ₹151,450.00, reflecting a 4.48% increase. This milestone comes after the company reported a 33% year-on-year rise in consolidated net profit to ₹492.74 crore for Q4 FY25, with revenue growing 11.43% to ₹7,074.82 crore. The EBITDA margin also expanded by 337 basis points quarter-on-quarter to 15%. The all-time high is driven by robust financial results and positive analyst sentiment. CLSA, on May 8, 2025, reiterated a 'buy' rating and set a target price of ₹1,68,426, indicating a 20% upside. The company's recent announcement of a final dividend of ₹229 per share for FY25, with a record date of July 18, 2025, further signals confidence in its financial health and commitment to shareholder returns. MRF has consistently demonstrated resilience, often outperforming its peers and the broader auto sector in recent trading sessions. The company's trading window for insiders is closed from July 1, 2025, until 48 hours after the Q1 FY26 results, signaling the upcoming release of its quarterly earnings. The final dividend payment, if approved at the AGM on August 7, 2025, is scheduled for on or after August 18, 2025.

Apollo Tyres shares advanced by 0.50% to ₹474.10 on Wednesday, July 9, 2025, marking a gain of ₹2.35 from its previous close of ₹471.75. This movement was accompanied by a notable surge in trading volume, with 1.95 million shares traded across NSE and BSE, significantly higher than its 1-month average volume of 1.35 million shares.

The positive sentiment follows recent "Buy" recommendations from brokerages, with ICICI Securities setting a target of ₹555 and Motilal Oswal targeting ₹554 in May 2025. Additionally, the company has announced its 52nd Annual General Meeting on July 31, 2025, and a recommended final dividend of ₹5.00 per share for FY25, with July 11, 2025, as the record date. Investors are also awaiting the unaudited financial results for Q1 FY26, for which the trading window for designated persons closed on July 1, 2025.

MRF shares surged to a new 52-week high of Rs 151,450.00 on the NSE today, reflecting strong positive momentum. The stock is currently trading at Rs 151,435.00, marking a significant gain of 4.48% for the day. This fresh peak indicates robust investor confidence in the tyre manufacturer.

The strong performance of MRF, a constituent of the NIFTY MIDCAP 150 index, suggests positive sentiment within the broader automotive and ancillary sectors. This upward movement could be driven by various factors, including improving demand outlook or company-specific developments, contributing to its impressive daily percentage change.

Event Summary:

Ola Electric shares plunged to an all-time low of Rs 40.26 on the NSE today. The stock is currently trading at Rs 40.34, reflecting a decline of 1.03% from its previous close.

Impact Analysis:

This decline follows the company's challenging Q4 FY25 results, which saw consolidated adjusted revenue drop 39.3% QoQ to ₹649 crore and consolidated EBITDA loss widen significantly to ₹658 crore, with a margin of -101.4%. Vehicle deliveries also fell sharply by 38.9% QoQ to 51,375 units, impacted by one-time registration process issues and a ₹250 crore warranty provision. The market reaction indicates concerns over the deepening losses and operational headwinds.

Forward Outlook:

Despite the weak Q4, Ola Electric has provided a positive outlook for Q1 FY26, guiding for adjusted revenue of ₹800-850 crore and 65,000 deliveries. The company is focusing on cost reduction through 'Project Lakshya' and aims for Auto EBITDA breakeven at less than 25,000 units/month, with improved gross margins targeted for Q2 FY26.

Motherson Sumi Wiring India (MSW) shares saw a marginal gain of 0.37% to trade at ₹64.84 on July 9, 2025. This movement was accompanied by high trading volume, indicating increased investor activity in the stock, which is part of the NIFTY MIDCAP 150 index.

The recent surge in volume follows the company's announcement on July 7, 2025, of the successful approval of its 1:2 bonus share issue via postal ballot. The bonus shares are anticipated to be credited to eligible shareholders by July 28, 2025. Additionally, the company recently appointed Mr. Gulshan as its new CFO, effective July 2, 2025, and closed its trading window on July 1, 2025, in anticipation of its Q1 FY26 financial results.

Ola Electric Mobility shares touched a new 52-week low of ₹40.42 on BSE today, currently trading at ₹40.46, down 0.74%. This decline follows the company's challenging financial performance for Q4 FY25 and the full fiscal year 2025.

The stock's downturn is largely attributed to the significant deterioration in its latest financial results. For Q4 FY25, consolidated revenue plummeted 60.5% year-on-year to ₹649 crore, while the consolidated net loss widened substantially to ₹870 crore. For the full FY25, the consolidated net loss expanded to ₹2,276 crore from ₹1,584 crore in FY24, with operating cash flow remaining negative at ₹2,391 crore. These figures, coupled with the auditor's 'Emphasis of Matter' on the 'Going Concern' assumption, have likely fueled investor concerns regarding the company's profitability and financial stability. Despite the current challenges, Ola Electric aims for Auto segment EBITDA profitability in FY26 and projects improved gross margins, with a target of approximately 35% by Q2 FY26.

FSN E-Commerce Ventures, commonly known as Nykaa, witnessed a significant surge, gaining 5.36% to trade at ₹213.44. This marks the third consecutive day of gains for the stock, positioning it among the top performers on the NIFTY MIDCAP 150 index. The positive momentum is largely attributed to a strong Q1FY26 business update announced on July 6, 2025, which has generated considerable buying interest and led to high trading volumes.

The stock's current uptrend is supported by bullish technical indicators, with analysts previously setting target prices of ₹218 and ₹230. Nykaa aims for its fashion business to achieve breakeven by FY26, with EBITDA margins projected to reach mid-single digits by FY28, further bolstering investor confidence.

FSN E-Commerce Ventures (Nykaa) shares surged by 5.36% to trade at ₹213.44 on July 9, accompanied by high trading volume. This marks a significant upward movement for the beauty and personal care retailer, extending its gains for the third consecutive day.

The stock's current price of ₹213.44 reflects a 5.36% increase from its previous close of ₹202.55 on July 8. This positive momentum, occurring with a notable volume surge, indicates heightened investor interest in Nykaa, a constituent of the NIFTY MIDCAP 150 index. The surge comes despite recent reports of early investors divesting a 2.1% stake and a significant 83.5% year-on-year decline in net profit for March 2025.

Max Healthcare Institute Limited (MHI) experienced a significant decline of 3.60% today, with its share price falling to ₹1,249.00. This movement occurred on high volume, indicating notable trading activity. The stock is a constituent of the NIFTY MIDCAP 150 index and was previously noted among the top losers on the index on July 9, 2025, with a 2.12% fall to ₹1,268.20.

The current drop extends recent corrections, contrasting with the "very bullish" market sentiment reported as of July 9, 2025. Despite this, analysts had recently issued "Buy" recommendations for MHI, citing strong financial performance and potential inclusion in the Nifty 50 index. Nuvama's report on July 3, 2025, suggested MHI's potential entry into the Nifty 50 during the September 2025 rejig, which could trigger passive buying of over $400 million. This long-term positive outlook remains a key factor for the stock, even as it undergoes short-term price adjustments.

Emami, Global Health, FSN E-Co Nykaa, Mankind Pharma, and Coromandel International emerged as the top gainers in the NIFTY MIDCAP 150 index today. Emami led the pack, surging 5.53% to ₹605.30, followed closely by Global Health, which gained 5.33% to ₹1,283.00.

The strong performance of these midcap stocks indicates positive investor sentiment across diverse sectors. FSN E-Co Nykaa rose 4.4% to ₹211.51, while Mankind Pharma advanced 3.83% to ₹2,524.90. Coromandel International also saw significant gains, climbing 3.76% to ₹2,290.50.

The NIFTY MIDCAP 150 index saw notable declines today, with several key constituents among the top losers. Union Bank of India fell by 3.93% to ₹144.35, Max Healthcare Institute dropped 3.69% to ₹1,247.90, and Phoenix Mills declined 3.66% to ₹1,517.00. Godrej Properties was down 2.48% at ₹2,253.00, and Hindustan Zinc lost 2.44%, trading at ₹425.55.

The declines are attributed to specific company-centric developments and broader market sentiment. Union Bank's fall follows recent news of the abrupt cessation of an Executive Director due to government intervention, raising corporate governance concerns, alongside general profit booking in PSU banks. Max Healthcare's shares reacted to a setback in an ongoing tax dispute involving its subsidiary, where an appeal was rejected, with the financial impact remaining undisclosed. Phoenix Mills and Godrej Properties were impacted by Nomura initiating 'Reduce' ratings on both stocks, citing concerns over slowing growth, stretched valuations, and weaker pre-sales momentum for Godrej Properties. Hindustan Zinc's shares plunged following a report from Viceroy Research alleging "looting" of its resources through related-party deals and unjustifiable brand fees, compounded by US President Trump's threat of a 50% tariff on copper imports.

The NIFTY MIDCAP 150 index saw strong performance today, with several stocks registering significant gains. Emami led the surge, closing at 605.30 with a 5.53% increase, indicating robust investor confidence in the FMCG sector. Global Health followed closely, rising 5.33% to 1,283.00, reflecting positive sentiment in the healthcare space. FSN E-Co Nykaa also posted a notable gain of 4.4%, reaching 211.51.

Other key contributors to the midcap index's upward trend included Mankind Pharma, which advanced 3.83% to 2,524.90, and Coromandel International, gaining 3.76% to close at 2,290.50. These movements highlight broad-based buying interest across diverse sectors such as pharmaceuticals and chemicals within the midcap segment.

Key Data Points:

Company	Closing Price	% Change
Emami	605.30	5.53%
Global Health	1,283.00	5.33%
FSN E-Co Nykaa	211.51	4.4%
Mankind Pharma	2,524.90	3.83%
Coromandel Int	2,290.50	3.76%

Schaeffler India's stock gained 0.44% to trade at ₹4220.30 on July 9, 2025, experiencing a notable volume surge. The stock, part of the NIFTY MIDCAP 150 index, saw increased investor activity, with a current trading volume of 113,819 shares, significantly higher than its 1-month average volume of 75,754 shares.

The stock's previous close was ₹4201.90. Schaeffler India has shown strong short-term performance, with a 4.56% gain over the last week and a 41.51% gain over the past three months. Its 52-week high stands at ₹4364.80, and its market capitalization is ₹65,958 crore. The increased volume and positive price movement suggest heightened investor interest, possibly in anticipation of the company's upcoming Q1 FY26 financial results, for which the trading window was recently closed effective July 1, 2025. Recent institutional activity also includes Societe Generale acquiring 80,807 shares at ₹4,199.40 per share on June 12, 2025.

The NIFTY MIDCAP 150 saw significant declines today, with Union Bank leading losses at -3.93%, followed by Max Healthcare (-3.69%), Phoenix Mills (-3.66%), Godrej Properties (-2.48%), and Hindustan Zinc (-2.44%). The drops in Phoenix Mills and Godrej Properties were primarily driven by 'Reduce' ratings from Nomura, while Hindustan Zinc was impacted by a critical report from Viceroy Research. Union Bank's decline follows recent leadership changes and broader profit booking in PSU banks.

Key Data Points:

• Union Bank: ₹144.35 (-3.93%)


• Max Healthcare: ₹1,247.90 (-3.69%)


• Phoenix Mills: ₹1,517.00 (-3.66%)


• Godrej Prop: ₹2,253.00 (-2.48%)


• Hind Zinc: ₹425.55 (-2.44%)

Impact Analysis: Nomura initiated 'Reduce' calls on Phoenix Mills (target ₹1,400) and Godrej Properties (target ₹1,900), citing slowing retail consumption growth and stretched valuations for Phoenix Mills, and weaker pre-sales momentum and stretched valuations for Godrej Properties. Hindustan Zinc's fall was exacerbated by Viceroy Research's report, which alleged "looting" of HZL's resources by its parent Vedanta through related-party deals and brand fees. Union Bank's decline is influenced by recent top-level management changes and a general trend of profit booking in PSU bank stocks. Max Healthcare's drop comes after a subsidiary's appeal in a tax dispute was rejected, adding to negative sentiment despite recent strong financial performance.

Forward Outlook: Max Healthcare's management intends to file a further appeal in the tax dispute. Union Bank's board is considering a capital plan to raise up to ₹6,000 crore. Hindustan Zinc faces ongoing scrutiny following the Viceroy report and previous fines for board composition non-compliance.

APL Apollo Tubes shares declined by 2.21% to trade at ₹1703.00. This movement follows the company's announcement of its Q1 FY26 sales volume, which stood at 794,350 Ton. While this represents a strong 10% year-on-year (YoY) growth compared to Q1 FY25, it marks a 7% quarter-on-quarter (QoQ) decline from Q4 FY25. The core 'Apollo Structural' segment, the largest contributor, saw an 11.9% QoQ drop, contributing significantly to the overall sequential dip.

The sequential decline in sales volume, particularly in the key structural segment, appears to be influencing investor sentiment. The company has also announced the closure of its trading window from July 1, 2025, in anticipation of its unaudited financial results for Q1 FY26, which are yet to be announced.

Hindustan Petroleum Corporation (HPC) shares experienced a decline, falling by 2.08% to ₹443.30 on July 9, 2025. The stock is a component of the NIFTY MIDCAP 150 index. The company recently recommended a final dividend of ₹10.50 per equity share for FY 2024-25, with a record date of August 14, 2025. Additionally, HPCL's trading window closed on July 1, 2025, in anticipation of its unaudited financial results for the first quarter ending June 30, 2025 (Q1 FY26).

The market awaits the announcement of HPCL's Q1 FY26 results, which will provide further insights into the company's operational and financial performance. The company has also made recent routine disclosures regarding senior management superannuations and public notices for unclaimed dividends, in compliance with SEBI regulations.

The NIFTY MIDCAP 150 index is witnessing notable declines today, with several key constituents experiencing significant losses. Union Bank leads the pack, trading down 4.07% at ₹144.14. Other top losers include Phoenix Mills, which fell 3.44% to ₹1,520.50, and Max Healthcare, down 3.36% at ₹1,252.10. Hind Zinc also saw a decline of 2.72% to ₹424.35, while 360 ONE WAM dropped 2.39% to ₹1,191.20.

These movements indicate a broad-based negative sentiment affecting specific midcap stocks across various sectors including banking, real estate, healthcare, metals, and financial services. The declines in these prominent midcap names contribute to the overall weakness observed within the NIFTY MIDCAP 150 index today.

The NIFTY MIDCAP 150 index saw significant gains today, with Global Health leading the pack, rising 5.25% to ₹1,282.00. Emami followed with a 5.14% increase to ₹603.10, while Mankind Pharma climbed 3.94% to ₹2,527.50. FSN E-Co Nykaa gained 3.72% to ₹210.13, and Coromandel International was up 3.58% at ₹2,286.60.

Global Health's rise comes amidst recent proactive investor engagements, including multiple one-to-one meetings with prominent institutional investors like Vontobel, BlackRock, and Aberdeen, and an ESOP allotment at ₹1144 per share, signaling strong internal confidence. Emami's gain follows its strategic move to extend the redemption of preference shares by four years with a higher premium, aimed at managing liquidity. Mankind Pharma's positive momentum is supported by its recent participation in investor conferences in London and the incorporation of a new wholly-owned non-profit subsidiary. Coromandel International's stock reacted positively to the proposed final and special dividends for FY24-25, indicating robust financial performance. All three companies (Global Health, Emami, Mankind Pharma) have also announced the closure of their trading windows in anticipation of their Q1 FY26 financial results, with Coromandel International's AGM and dividend record date also approaching.

Endurance Technologies shares advanced by 2.07% to trade at ₹2676.80. The stock is a constituent of the NIFTY MIDCAP 150 index. The company had previously indicated on June 25, 2025, that significant share price movements were due to external factors and broader market dynamics, rather than any unpublished price-sensitive information or internal developments. Moneycontrol's analysis as of July 7, 2025, reflected a very bullish sentiment for the stock.

The NIFTY MIDCAP 150 index is seeing significant downward pressure, with several key constituents registering notable losses. Union Bank led the decline, dropping 4.07% to trade at ₹144.14. This movement highlights a broader negative sentiment impacting specific midcap stocks today.

Other prominent losers include Phoenix Mills, which fell 3.44% to ₹1,520.50, and Max Healthcare, down 3.36% at ₹1,252.10. Hind Zinc also saw a decrease of 2.72% to ₹424.35, while 360 ONE WAM declined 2.39% to ₹1,191.20. These individual stock performances are contributing to the overall weakness observed in the NIFTY MIDCAP 150 index.

The NIFTY MIDCAP 150 index saw strong performance from several stocks today. Global Health led the gains, rising 5.25% to ₹1,282.00, followed by Emami with a 5.14% increase to ₹603.10. Mankind Pharma, FSN E-Co Nykaa, and Coromandel International also posted significant gains, contributing to the positive sentiment in the midcap segment.

KEI Industries shares experienced a price fall of 2.20%, trading at ₹3688.20. This movement was noted as a market alert for the company, which is a constituent of the NIFTY MIDCAP 150 index. The immediate cause for this specific price movement is not detailed in the available information.

Recent corporate developments for KEI Industries include the scheduling of its Annual General Meeting for July 30, 2025, and a Board meeting on July 22, 2025, to consider and approve the un-audited financial results for the quarter ending June 30, 2025. The company also recently received credit rating upgrades from India Ratings and ICRA, indicating improved financial stability and credit profile.

Mankind Pharma's shares surged by 4.10% to ₹2531.50, indicating significant upward momentum and triggering a market alert for high volume and unusual activity. The stock is a constituent of the NIFTY MIDCAP 150 index.

The company's consolidated annual revenue for FY25 stood at ₹12,207.44 crore, marking a 19% year-on-year increase, with consolidated net profit reaching ₹1,998.88 crore, up 3.4% YoY. For Q4 FY25, consolidated net sales rose 26.15% to ₹3,079.37 crore, though consolidated net profit declined by 10.71% to ₹420.77 crore. Motilal Oswal had previously issued a 'Buy' rating with a target price of ₹2910 for Mankind Pharma. The company's trading window for designated persons closed on July 1, 2025, ahead of its Q1 FY26 financial results, and its 34th Annual General Meeting is scheduled for August 7, 2025.

Bandhan Bank shares advanced by 2.03% to trade at ₹178.25. This movement follows the bank's recent Q1 FY26 provisional business updates, which indicated mixed performance metrics. The bank reported a 16.1% year-on-year increase in total deposits to ₹1.55 lakh crore and a 6.4% rise in loans and advances to ₹1.33 lakh crore. However, CASA deposits saw a 5.8% decline year-on-year, leading to a drop in the CASA ratio to 27.06% from 33.37% in Q1 FY25.

The bank's Liquidity Coverage Ratio stood at approximately 178.28% as of June 30. Looking ahead, Bandhan Bank has scheduled its 11th Annual General Meeting (AGM) for August 21, 2025, and has fixed August 14, 2025, as the record date for a potential dividend, subject to shareholder approval at the AGM. The trading window for designated persons remains closed from July 1, 2025, until 48 hours after the Q1 FY26 results are declared.

SBI Cards and Payment Services saw its shares rise by 2.01% to ₹937.20 on July 9, 2025. The stock, part of the NIFTY MIDCAP 150 index, gained ₹18.30 from its previous close of ₹918.75. Today's trading saw the stock open at ₹924.50, reaching a high of ₹937.75 and a low of ₹920.05, with a trading volume of 616,540 shares. The company's market capitalization stands at ₹89,162 crore.

This upward movement follows recent volatility for SBI Cards. On July 2, the stock had dropped 2% after Goldman Sachs downgraded it to 'Neutral', and on June 19, it was among the midcap losers, falling over 3.6%. Conversely, the stock had rallied 4% on June 6 after the RBI Governor indicated abated stress in unsecured loans and credit card segments. The company also recently received a show cause notice from the GST Department regarding disallowance of input tax credit totaling ₹81.93 crore for FY 2018-19 to FY 2020-21. The company's trading window for designated persons closed on July 1, 2025, and will reopen 48 hours after the declaration of its Q1 FY26 financial results, signaling upcoming earnings as a significant event for the stock.

Sona BLW Precision Forgings (SONACOMS) shares declined by 2.34% to ₹450.50, trading with high volumes. The stock is currently at ₹450.50, down from its previous close of ₹461.30, and is part of the NIFTY MIDCAP 150 index. The trading volume for the day stands at 3,391,673 shares.

The decline occurs despite recent positive developments, including ICICI Prudential Mutual Fund increasing its stake to 5.05% on July 1, signaling a bullish institutional outlook. The company also announced strategic plans to expand into new mobility solutions and domestic magnet production. However, a June 23 report indicated a "very bearish" investor sentiment for the stock. The 52-week high for Sona BLW is ₹768.65, and its 52-week low is ₹380.00, with a current market capitalization of ₹28,061 crore.

Container Corporation of India (CONCOR) shares surged by 2.67% to ₹614.35, experiencing a significant jump in trading volume. This upward movement follows the recent commencement of trading for its 1:4 bonus shares and positive developments in its business strategy. The positive momentum in CONCOR's stock is primarily driven by the trading of new bonus shares, which began on July 8, 2025, following the 1:4 bonus issue approved by shareholders. This corporate action enhances liquidity and is perceived positively by the market.

Additionally, the company's recent launch of specialized tank containers for bulk cement transportation, a first-of-its-kind service in India, signals strategic business expansion and innovation. Jefferies also maintained a 'Buy' rating with a raised target price of ₹825, further bolstering investor confidence. Investors are now anticipating CONCOR's financial results for the first quarter (Q1) of FY26, for which the trading window for designated persons closed on July 1, 2025.

The NIFTY MIDCAP 150 index saw notable declines among its constituents as of 2:00 PM UTC. Union Bank emerged as the top loser, with its shares falling 3.59% to ₹144.85. Following closely, Phoenix Mills dropped 3.28% to ₹1,523.00. Max Healthcare also experienced a significant downturn, decreasing by 2.96% to ₹1,257.40. Other prominent decliners included Hind Zinc, which was down 2.51% at ₹425.25, and Sona BLW, trading lower by 2.33% at ₹450.55. These movements reflect a negative sentiment impacting these specific midcap stocks during the trading session.

The NIFTY MIDCAP 150 index saw strong performance today, with several stocks registering significant gains. Global Health led the pack, surging 6.41% to ₹1,296.20, driven by higher volumes and consistent financial growth, reflecting exceptional profit velocity. Emami followed with a 5.24% gain, reaching ₹603.65, supported by positive movement and steady revenue growth. Mankind Pharma advanced 3.91% to ₹2,526.70, while FSN E-Co Nykaa climbed 3.86% to ₹210.40, recovering from recent declines. MRF also saw a notable increase of 3.61%, trading at ₹150,180.00, on a sharp volume uptick.

The broader market is navigating tariff jitters, with US stock futures stalling after President Trump's comments on trade tensions. Despite this, Indian equities are holding ground. The positive movements in these midcap stocks indicate specific company-driven momentum and investor interest in their respective sectors.

Sona BLW Precision Forgings (SONACOMS) shares declined by 2.34% to ₹450.50, experiencing high trading volumes. The stock opened at ₹463.10 and touched a low of ₹447.30, with a total volume of 3.39 million shares traded today. This movement follows a previous decline on June 23, 2025, where shares fell over 1.3% with high volume, indicating persistent bearish sentiment.

Despite recent positive developments such as ICICI Prudential Mutual Fund increasing its stake to 5.05% on July 1, 2025, and the company's strong FY25 financial results (12% YoY revenue growth, 16% YoY PAT growth, and a robust ₹242 billion order book), the stock is under pressure. The company is also strategically expanding into new mobility solutions and plans domestic magnet production to reduce import reliance. The upcoming 29th Annual General Meeting on July 25, 2025, will address these strategic shifts and a recommended final dividend of ₹1.60 per share.

The NIFTY MIDCAP 150 index saw several of its constituents register significant declines today. Union Bank led the top losers, dropping 3.59% to ₹144.85. Phoenix Mills followed with a 3.28% decrease, closing at ₹1,523.00, while Max Healthcare shed 2.96% to ₹1,257.40. Hind Zinc and Sona BLW also experienced notable losses, declining by 2.51% to ₹425.25 and 2.33% to ₹450.55 respectively.

These declines indicate a negative sentiment impacting these specific midcap stocks, directly affecting investors holding positions in these companies within the NIFTY MIDCAP 150 index.

The NIFTY MIDCAP 150 index saw significant upward movement today, with several stocks emerging as top gainers. Global Health led the pack, surging 6.41% to trade at ₹1,296.20, driven by higher volumes and consistent financial growth, reflecting exceptional profit velocity. Emami followed with a 5.24% gain, reaching ₹603.65, supported by positive movement and steady revenue growth. Mankind Pharma advanced 3.91% to ₹2,526.70, while FSN E-Co Nykaa rose 3.86% to ₹210.40. MRF also saw a notable increase of 3.61%, trading at ₹150,180.00, reaching a 52-week high on sharp volume uptick.

These individual stock performances highlight company-specific positive sentiment and strong fundamentals, allowing them to outperform despite broader market concerns regarding tariff jitters and US trade policy. The gains in Global Health, Emami, and Mankind Pharma indicate investor interest in the healthcare and consumer sectors, while MRF's surge points to strength in the auto ancillary space.

Cummins India shares advanced by 1.49% to ₹3529.90, experiencing a notable surge in trading volume. This movement follows the company's recent strategic product launch and robust financial performance for the fiscal year ended March 31, 2025.

The positive sentiment is likely driven by the recent launch of Battery Energy Storage Systems (BESS) on June 26, expanding Cummins India's sustainable solutions portfolio. Fundamentally, the company reported strong FY25 consolidated revenue growth of 15.45% to ₹10,390.69 crore and a 16.24% increase in Net Profit After Tax (PAT) to ₹1,999.94 crore. Additionally, the board recommended a final dividend of ₹33.5 per share for FY25. The company's Board of Directors is scheduled to meet on August 7, 2025, to approve the unaudited financial results for Q1 FY26, with the trading window currently closed until August 9, 2025.

Cummins India stock advanced by 1.49% to trade at ₹3529.90, signaling high trading volume. This positive movement follows the company's recent announcement on July 3, 2025, of a recommended final dividend of ₹33.5 per equity share for FY25, representing a significant 1675% payout. This dividend proposal, subject to shareholder approval at the upcoming AGM on August 8, 2025, reflects strong financial performance.

The company also reported robust consolidated financial results for FY25, with revenue growing 15.45% year-on-year to ₹10,390.69 crore and Net Profit After Tax increasing by 16.24% to ₹1,999.94 crore. Additionally, Cummins India recently launched its Battery Energy Storage Systems (BESS) on June 26, 2025, expanding its sustainable solutions portfolio. The company anticipates double-digit revenue growth for FY26, driven by domestic demand, with its Board of Directors scheduled to approve Q1 FY26 results on August 7, 2025.

IRB Infrastructure Developers' stock declined by 2.04% to ₹48.44. This movement follows the National Stock Exchange's decision to remove IRB Infrastructure Developers from the F&O segment, effective from the August series. This deletion, announced on June 24, 2025, impacts the stock's trading dynamics.

The company recently closed its trading window from July 1, 2025, in anticipation of its Q1 FY26 financial results, signaling an imminent earnings announcement. While existing F&O contracts for June, July, and August 2025 will continue to trade, no new contracts will be issued for new expiry months starting August 29, 2025.

360 ONE WAM shares declined by 2.12% to trade at ₹1,194.50 on the NIFTY MIDCAP 150 index. This movement follows recent disclosures of significant promoter share sales. On June 26, Shilpa Bhagat, a member of the promoter group, sold 18,03,284 equity shares through a market sale, reducing her holding and the overall promoter and PAC group's stake from 6.71% to 6.27%. Concurrently, promoter Mr. Yatin Shah also sold 13,00,000 equity shares via an open market transaction on the same day, further decreasing the promoter group's holding from 7.06% to 6.74%.

These open market sales by key promoters, even if for personal financial planning, can be interpreted by investors as profit-booking or a signal regarding the stock's valuation, potentially contributing to the negative sentiment observed today. The company's subsidiary, 360 ONE Distribution Services Limited, also recently received a ₹25 lakh penalty from MCXCCL for alleged false reporting, though the company stated it has no material financial impact and intends to appeal.

Nippon Life India Asset Management (RNL) shares advanced by 2.02%, trading at Rs 804.00. This upward movement places the stock within the NIFTY MIDCAP 150 index. The company, which manages a total AUM of Rs 654,112 crore as of March 31, 2025, has experienced significant price volatility, having reached a 52-week high of Rs 821.95 on June 9, 2025, and a 52-week low of Rs 498.05 on April 7, 2025.

This price rise comes ahead of the company's Board meeting scheduled for July 28, 2025, where it will consider and approve the unaudited financial results for the quarter ending June 30, 2025. While the company reported a 13% decrease in consolidated profit after tax for Q4 FY25, its operational revenue climbed by 21% to Rs 566.5 crore in the same period, and it saw a 47.3% YoY growth in net profit in the September 2024 quarter. The current positive sentiment could be influenced by anticipation surrounding the upcoming Q1 FY26 results.

The NIFTY MIDCAP 150 index saw several stocks decline today, with Union Bank of India leading losses at -3.67%, followed by Phoenix Mills (-3.56%), Max Healthcare (-2.87%), Hind Zinc (-2.6%), and Sona BLW (-2.1%). This movement reflects varied company-specific developments and broader market sentiment.
Union Bank's decline follows recent leadership changes, including the conclusion of its MD & CEO's tenure and the abrupt cessation of an Executive Director's appointment, alongside a planned capital raise of up to ₹6,000 crore. Phoenix Mills' shares fell after Nomura initiated a 'reduce' rating, citing concerns over slowing retail consumption growth and stretched valuations, aligning with its Q1 FY26 revenue and net profit declines. Max Healthcare's drop comes despite strong FY25 financial performance and potential Nifty 50 inclusion, possibly influenced by a recent tax dispute setback for its subsidiary. Hind Zinc's shares extended losses amid a broader metal sector downturn and recent stake sale by promoter Vedanta, coupled with mixed Q1 provisional production data. Sona BLW's shares also declined, following a leadership transition with the passing of its Chairman, though the company has appointed a new Chairperson and is pursuing strategic expansion into new mobility solutions.

The NIFTY MIDCAP 150 index saw several stocks post significant gains today, July 9, 2025. Global Health led the pack, surging 6.52% to ₹1,297.50. Emami followed with a 4.57% increase, closing at ₹599.80, while Mankind Pharma climbed 4.21% to ₹2,534.00. FSN E-Co Nykaa and MRF also recorded notable gains of 3.85% and 3.8% respectively, reaching ₹210.39 and ₹150,460.00.

Recent corporate developments for these top gainers include Global Health's ongoing investor engagements with prominent firms like BlackRock and Aberdeen, alongside a recent allotment of 110,000 new equity shares under ESOP and LTIP schemes, generating approximately ₹10.30 crore. Mankind Pharma has been in focus due to its participation in investor conferences in London and the incorporation of a new wholly-owned subsidiary, KINDCARE FOUNDATION. MRF has announced its 64th Annual General Meeting for August 7, 2025, with July 18, 2025, set as the record date for its final dividend. Both Mankind Pharma and MRF have also initiated trading window closures from July 1, 2025, in anticipation of their Q1 FY26 financial results. No specific recent corporate announcements were available for Emami or FSN E-Co Nykaa in the provided context.

The NIFTY MIDCAP 150 index saw several stocks decline today, with Union Bank of India leading the losses, down 3.67% to ₹144.73. This follows recent leadership changes, including the cessation of its Executive Director due to a Central Government cancellation on June 24, 2025, a development noted as a negative signal for corporate governance. The bank also announced a board meeting on June 25, 2025, to approve a capital plan to raise up to ₹6,000 crore, which could lead to equity dilution. Phoenix Mills dropped 3.56% to ₹1,518.70 after Nomura initiated coverage with a 'reduce' call and a ₹1,400 target price, citing slowing retail consumption growth and stretched valuations. Max Healthcare fell 2.87% to ₹1,258.50, impacted by the rejection of a tax appeal for its subsidiary on July 1, 2025, with the financial quantum of the dispute undisclosed. Hind Zinc declined 2.6% to ₹424.85, continuing a downward trend after its parent Vedanta sold a 1.6% stake on June 18, 2025, and amid a hawkish stance from the US Federal Reserve. Sona BLW Precision Forgings was down 2.1% to ₹451.60; despite recent positive developments like strong FY25 results and a new chairperson, Motilal Oswal had maintained a 'Neutral' rating on May 7, 2025, noting that valuations appeared expensive.

The NIFTY MIDCAP 150 index saw significant upward movement today, with Global Health leading the gains, rising 6.52% to ₹1,297.50. Other top performers included Emami, up 4.57% to ₹599.80, Mankind Pharma, which gained 4.21% to ₹2,534.00, FSN E-Co Nykaa advancing 3.85% to ₹210.39, and MRF increasing 3.8% to ₹150,460.00.

Global Health's surge follows its active investor engagement, including recent meetings with major institutional investors like Vontobel, BlackRock, and Aberdeen, alongside an employee stock purchase plan at a premium price, signaling strong internal confidence. Mankind Pharma also saw positive sentiment, driven by its proactive participation in investor conferences and the establishment of a new CSR-focused subsidiary. MRF's gain is linked to its recent announcement of a final dividend and its record date, indicating a commitment to shareholder returns. Emami's rise comes despite its recent audited FY25 results showing a significant decline in key financial metrics and ongoing capital restructuring efforts to manage liquidity. For FSN E-Co Nykaa, the movement appears to be market-driven without specific recent corporate announcements in the provided context. All four companies (Global Health, Emami, Mankind Pharma, and MRF) have closed their trading windows in anticipation of their Q1 FY26 financial results.

APL Apollo Tubes experienced a price fall of 2.10% today, with its stock trading at ₹1704.90. This movement places the company within the NIFTY MIDCAP 150 index, reflecting a notable decline in its share value during the trading session.

The immediate impact of this decline is a reduction in the stock's market valuation. Investors will be observing if this downward trend continues or if the stock finds support at current levels.

Mangalore Refinery and Petrochemicals (MRPL) shares gained 2.13% to trade at ₹147.91, reflecting positive market sentiment. This upward movement follows several strategic announcements by the company. MRPL recently secured a US patent for its in-house technology to produce Isobutyl Benzene, a key pharmaceutical intermediate, signaling strong R&D capabilities and potential diversification into new revenue streams. Additionally, the company has made key senior management appointments, including Executive Directors for Finance, Marketing & Business Development, and Refinery, indicating robust internal succession planning and a strategic focus on operational stability and growth.

Investors will likely monitor the progress of the patented technology's commercialization and await the upcoming Q1 FY2026 financial results, for which the trading window has been closed. The stock's performance is currently influenced by these positive developments in its operational and strategic leadership, alongside its innovation efforts.

Mangalore Refinery and Petrochemicals (MRPL) saw its stock price rise by 2.13% to ₹147.91. This positive movement is primarily driven by the recent grant of a US patent for its in-house developed Isobutyl Benzene (i-BB) technology, which signifies strong R&D capabilities and potential for strategic diversification into the pharmaceutical sector. The company's focus on commercializing this technology, including setting up a pilot plant, is viewed as a future growth driver.

Further bolstering market sentiment are the recent key senior management appointments, including the Executive Director (Refinery), Executive Director (Finance), and Executive Director (Marketing and Business Development). These appointments, largely internal promotions of experienced candidates, signal operational stability, strong succession planning, and a proactive stance towards growth and market expansion. Investors will now monitor the progress of i-BB commercialization and await the upcoming Q1 FY2026 unaudited financial results, for which the trading window is currently closed.

The NIFTY MIDCAP 150 index saw significant gains today, with Global Health leading the pack, surging 7.1% to ₹1,304.60. Other notable gainers included Emami, up 4.6% to ₹600.00, Mankind Pharma, rising 4.2% to ₹2,533.80, FSN E-Co Nykaa gaining 3.83% to ₹210.35, and MRF, which climbed 3.8% to ₹150,455.00.

For **Global Health**, the recent allotment of 110,000 new equity shares, including 90,000 under the Employee Stock Purchase Scheme at a substantial issue price of ₹1144 per share, generated ₹10.30 crore cash inflow and signals strong internal confidence. The company's active engagement with institutional investors, including BlackRock and Aberdeen, also indicates robust investor relations. **Emami**'s gain follows its Q4 FY25 results, which showed a QoQ improvement in PAT (up 130.59%) and revenue (up 4.54%), potentially signaling early signs of stabilization despite a weak FY25 overall. The company's proposal to extend preference share redemption to manage liquidity, albeit with a higher premium, is a strategic cash management decision. **Mankind Pharma**'s rise comes amidst its participation in international investor conferences and the recent incorporation of KINDCARE FOUNDATION, a new wholly-owned subsidiary focused on social welfare, enhancing its corporate image. For **MRF**, the announcement of its 64th Annual General Meeting and the record date for its final dividend, payable post-AGM approval, reflects a commitment to shareholder returns.

Investors will closely monitor the upcoming Q1 FY26 financial results for Global Health, Emami, and Mankind Pharma, as their trading windows are currently closed in anticipation of these announcements. MRF's dividend payment, subject to AGM approval, will also be a key event.

The NIFTY MIDCAP 150 index saw significant upward movement today, with several key stocks posting notable gains. Global Health led the pack, surging 7.1% to ₹1,304.60, followed by Emami which rose 4.6% to ₹600.00. Mankind Pharma gained 4.2% to ₹2,533.80, while FSN E-Co Nykaa and MRF also contributed to the rally, increasing by 3.83% to ₹210.35 and 3.8% to ₹150,455.00 respectively.

Global Health's rise is supported by recent positive corporate actions, including employee share allotments and active investor engagement through multiple analyst meetings. Emami's gain follows its board's approval to restructure preference shares, extending the redemption period to manage liquidity, a move seen as prudent cash management despite weak FY25 results. Mankind Pharma's performance is linked to upcoming Q1 FY26 results and recent proactive investor interactions. MRF also saw an uptick ahead of its Q1 FY26 results and the announcement of a final dividend, signaling a commitment to shareholder returns. Investors will closely monitor the upcoming Q1 FY26 earnings for these companies, along with Emami's preference share restructuring and MRF's dividend payment.

The NIFTY MIDCAP 150 index experienced notable declines among its constituents today, with several key stocks registering significant losses. Phoenix Mills led the downturn, shedding 3.98% of its value, closing at ₹1,512.10. Other prominent losers included Union Bank, Hind Zinc, Max Healthcare, and Sona BLW, indicating a broad-based negative sentiment across diverse sectors within the midcap space.

The top five losers on the NIFTY MIDCAP 150 were:

• Phoenix Mills: ₹1,512.10 (-3.98%)


• Union Bank: ₹144.90 (-3.56%)


• Hind Zinc: ₹422.50 (-3.14%)


• Max Healthcare: ₹1,257.80 (-2.93%)


• Sona BLW: ₹450.15 (-2.42%)

This performance reflects a negative trend impacting sectors such as real estate, banking, metals, healthcare, and auto ancillaries. Investors will be closely monitoring the broader market sentiment and any specific company-related news that might influence these stocks in the upcoming trading sessions.

Glenmark Pharma's stock declined by 2.03% to ₹1793.30 on July 9, 2025, trading on the NIFTY MIDCAP 150 index. This movement follows the stock hitting an all-time high on July 7, 2025. Recent company developments include the USFDA issuing a Form 483 with five procedural observations for its Monroe facility on June 18, 2025. Conversely, Glenmark has also announced positive Phase 1 results for its myeloma drug ISB 2001, launched new oncology drugs BRUKINSA® and TEVIMBRA® in India, and appointed Mr. Anurag Mantri as Executive Director & Global CFO. Investors will monitor the company's response to the USFDA observations and the market reception of its new product launches.

MRF Limited's shares surged by 3.72% to ₹150,340.00 on July 9, 2025, trading with significantly high volume. The stock's current price is nearing its 52-week high of ₹150,995.00, reflecting strong market activity. Today's traded volume of 11,829 units is notably higher than the 1-week average of 5,853 units and the 1-month average of 7,727 units, indicating increased investor interest.

This upward movement follows recent corporate announcements, including the scheduling of the 64th Annual General Meeting for August 7, 2025, and the final dividend record date set for July 18, 2025. The company also recently reclaimed its position as India's most expensive stock. Investors will closely monitor the stock's performance leading up to the dividend record date and the upcoming Q1 FY26 earnings release, for which the trading window for insiders closed on July 1, 2025.

Hitachi Energy India's stock rose by 2.62% to ₹19,615.00, reflecting positive momentum and high trading volume. The company is a constituent of the NIFTY MIDCAP 150 index. This upward movement is primarily driven by the recent significant order from Power Grid Corporation of India Limited (POWERGRID) for 30 units of 765-kilovolt (kV) transformers, a material event under SEBI Regulation 30. This order strengthens Hitachi Energy India's order book and provides strong revenue visibility, signaling a bullish outlook for the power transmission and distribution sector. Additionally, the potential inclusion of Hitachi Energy India in the MSCI India Standard Index, which could bring an estimated $165 million in inflows, is contributing to the positive investor sentiment.

Investors will be closely watching the company's upcoming unaudited financial results for the quarter ending June 30, 2025, for further insights into its performance. The company's strategic shift towards program-based planning and its commitment to local manufacturing in Vadodara are also key factors for future growth.

The NIFTY MIDCAP 150 index saw several stocks decline significantly on July 9, 2025, with Union Bank of India leading the losses, down 3.87% to ₹144.43. This drop follows a cautious Q1 FY26 business update revealing a sequential decline in deposits and loan growth, alongside weak CASA deposits. Phoenix Mills also fell by 3.71% to ₹1,516.30, primarily due to Nomura initiating coverage with a 'Reduce' rating, citing concerns over weak retail consumption, slowing growth, and valuation. Hind Zinc declined 2.72% to ₹424.35 amid negative investor sentiment and a broader decline in domestic metal stocks. Max Healthcare Institute saw a 2.37% dip to ₹1,265.00, marking a notable shift, while Sona BLW Precision Forgings was down 2.16% to ₹451.35 following a recent downgrade by Bernstein. Investors will closely monitor upcoming quarterly results and brokerage reports for further cues on these stocks.

MRF shares witnessed a significant surge, gaining 3.72% to trade at ₹150,340.00 on July 9, 2025, accompanied by unusually high trading volume. The stock's current price is nearing its 52-week high of ₹150,995.00. Today's trading volume of 11,692 shares is notably higher than the previous day's 4,742 shares and the one-week average of 5,853 shares, indicating strong investor interest.

This upward movement follows recent corporate announcements, including the scheduling of MRF's 64th Annual General Meeting for August 7, 2025, and the fixing of July 18, 2025, as the record date for its final dividend. Such dividend announcements typically signal the company's financial confidence and commitment to shareholder returns. The stock has demonstrated robust performance over the past three months, with a gain of 33.07%. Investors will closely monitor the upcoming Q1 FY26 earnings release, for which the trading window is currently closed, and the final dividend approval at the AGM.

Global Health, Emami, Mankind Pharma, FSN E-Co Nykaa, and MRF emerged as the top gainers in the NIFTY MIDCAP 150 index today. Global Health led the pack, surging 6.64% to ₹1,299.00, followed by Emami with a 4.95% gain to ₹602.00, and Mankind Pharma rising 4.04% to ₹2,530.00. FSN E-Co Nykaa and MRF also posted strong gains of 3.95% to ₹210.59 and 3.77% to ₹150,410.00 respectively.

Global Health's rally appears to be fueled by recent active engagement with prominent institutional investors like Vontobel, BlackRock, and Aberdeen, signaling strong institutional interest, alongside employee share allotments at a high price indicating internal confidence. For Emami, despite a challenging FY25 with significant profit decline, a recent Q4 QoQ improvement and a strategic move to extend preference share redemption to manage liquidity, coupled with a dividend recommendation, might be contributing to positive sentiment. Mankind Pharma's gains could be linked to its upcoming Q1 FY26 results and recent participation in investor conferences in London, enhancing its visibility. MRF's positive movement follows the announcement of its 64th AGM and the record date for a final dividend payment, boosting investor confidence. Investors will closely watch the upcoming Q1 FY26 results for Global Health, Emami, Mankind Pharma, and MRF, along with Emami's preference share restructuring and MRF's dividend payment.

The NIFTY MIDCAP 150 index saw significant declines on July 9, 2025, with Union Bank of India leading the losses, down 3.87% to ₹144.43. This sharp drop in Union Bank shares was primarily triggered by a cautious Q1 FY26 business update, which revealed a sequential decline in deposits and loan growth, alongside weak CASA deposits. Phoenix Mills followed, shedding 3.71% to ₹1,516.30, after Nomura initiated coverage with a 'Reduce' rating, citing concerns over weak retail consumption growth and lower mall occupancy.

Other notable losers included Hindustan Zinc, down 2.72% to ₹424.35, amid negative investor sentiment and a broader decline in metal stocks. Max Healthcare Institute fell 2.37% to ₹1,265.00, experiencing a general decline in today's session. Sona BLW Precision Forgings also saw a 2.16% dip to ₹451.35, continuing a negative trend following a recent downgrade by Bernstein. Investors will closely monitor upcoming quarterly results and any further brokerage reports for these companies.

The NIFTY MIDCAP 150 index saw significant upward movement today, with Global Health, Emami, Mankind Pharma, FSN E-Co Nykaa, and MRF emerging as top gainers. Global Health surged by 6.64% to ₹1,299.00, Emami rose 4.95% to ₹602.00, Mankind Pharma gained 4.04% to ₹2,530.00, FSN E-Co Nykaa was up 3.95% at ₹210.59, and MRF climbed 3.77% to ₹150,410.00.

The gains are underpinned by recent corporate developments. Global Health's rally follows active investor engagement through multiple analyst meetings in June 2025 and the allotment of 110,000 new equity shares under ESOP/LTIP plans, signaling strong internal confidence. Emami's (referring to Emami Paper Mills Limited as per provided context) rise comes despite recent FY25 results showing significant year-on-year declines in PAT and EBITDA, possibly reacting to the board's approval of preference share term variations to manage liquidity and a fixed record date for dividend. Mankind Pharma's appreciation is linked to its participation in international investor conferences, enhancing visibility, and the incorporation of a new non-profit subsidiary. MRF's stock climbed after the announcement of its 64th AGM and the fixing of July 18, 2025, as the record date for its final dividend, reflecting a commitment to shareholder returns. Investors will closely monitor the upcoming Q1 FY26 financial results for Global Health, Emami Paper Mills, Mankind Pharma, and MRF, as all have announced trading window closures. The outcome of Emami Paper Mills' postal ballot for preference share term variation and MRF's dividend payment on or after August 18, 2025, will also be key events to watch.